Keywords
SARS-CoV-2, COVID-19, wastewater, wastewater-based epidemiology, RT-qPCR, 12
nucleic acid purification 13
14
15
16
17
18
19
20
21
22
23
1 Contributed equally to this work 24
25
26
* Corresponding Author: 27
Subhanjan Mondal 28
Email:
[email protected] 29
Address: Promega Corporation, 5430 E Cheryl Pkwy, Fitchburg, WI, 53711. 30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
2
Abstract
45
46
Studies have demonstrated that SARS-CoV-2 RNA can be detected in the feces of infected individuals. 47
This finding spurred investigation into using wastewater-based epidemiology (WBE) to monitor SARS-48
CoV-2 RNA and track the appearance and spread of COVID-19 in communities. SARS-CoV-2 is present 49
at low levels in wastewater, making sample concentration a prerequisite for sensitive detection and utility 50
in WBE. Whereas common methods for isolating viral genetic material are biased toward intact virus 51
isolation, it is likely that a relatively low percentage of the total SARS-CoV-2 RNA genome in 52
wastewater is contained within intact virions. Therefore, we hypothesized that a direct unbiased total 53
nucleic acid extraction method could overcome the cumbersome protocols, variability and low recovery 54
rates associated with the former methods. This led to development of a simple, rapid, and modular 55
alternative to existing purification methods. In an initial concentration step, chaotropic agents are added to 56
raw sewage allowing binding of nucleic acid from free nucleoprotein complexes, partially intact, and 57
intact virions to a silica matrix. The eluted nucleic acid is then purified using manual or semi-automated 58
methods. RT-qPCR enzyme mixes were formulated that demonstrate substantial inhibitor resistance. In 59
addition, multiplexed probe-based RT-qPCR assays detecting the N1, N2 (nucleocapsid) and E (envelope) 60
gene fragments of SARS-CoV-2 were developed. The RT-qPCR assays also contain primers and probes 61
to detect Pepper Mild Mottle Virus (PMMoV), a fecal indicator RNA virus present in wastewater, and an 62
exogenous control RNA to measure effects of RT-qPCR inhibitors. Using this workflow, we monitored 63
wastewater samples from three wastewater treatment plants (WWTP) in Dane County, Wisconsin. We 64
also successfully sequenced a subset of samples to ensure compatibility with a SARS-CoV-2 amplicon 65
panel and demonstrated the potential for SARS-CoV-2 variant detection. Data obtained here underscore 66
the potential for wastewater surveillance of SARS-CoV-2 and other infectious agents in communities. 67
68
69
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
3
Introduction
70
71
In late December of 2019, Chinese health authorities examined a new respiratory virus that caused 72
unexplained cases of severe pneumonia1. Subsequent sequencing identified the virus as a member of the 73
Coronavirus family, a group of enveloped RNA viruses that commonly infect birds, mammals, and 74
humans2. The novel virus, designated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), 75
is related to SARS-CoV and MERS-CoV, other respiratory viruses that can lead to fatal illness3. SARS-76
CoV-2 was determined to be the causative agent of the respiratory disease COVID-191,4. COVID-19 77
quickly evolved into a global pandemic, which at the time of this report has resulted in over 3.1 million 78
deaths worldwide (https://coronavirus.jhu.edu/map.html). 79
80
The rapid person-to-person spread of SARS-CoV-2 is in part due to the high infectiousness of viral 81
carriers5,6. Pre-symptomatic shedding is thought to drive a significant amount of viral spread, as the 82
highest risk of transmission occurs very early in the course of the disease5,6. Asymptomatic carriers of the 83
virus are also infectious and display similar viral loads in the respiratory system, despite exhibiting faster 84
viral clearance6-9. As traditional nasal swab testing approaches can be biased towards symptomatic viral 85
carriers10, viral surveillance methods that provide a widespread view of community infection are vital for 86
accurate monitoring and control of the ongoing pandemic. 87
88
Although infectious SARS-CoV-2 virions are rarely isolated from feces11, several reports early in the 89
COVID-19 pandemic demonstrated that SARS-CoV-2 can frequently (50%-70%) be detected in fecal 90
samples from both symptomatic and asymptomatic infected individuals9,12-15. Levels of SARS-CoV-2 91
RNA in feces are not correlated with the presence/absence of gastrointestinal illness or with overall 92
COVID-19 disease severity12, as is often the case with respiratory samples. Although SARS-CoV-2 viral 93
load is consistently higher in respiratory specimens, viral RNA in feces can be detected significantly 94
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
4
longer after initial symptom onset compared to nasal swab samples13,16. This aspect of SARS-CoV-2 fecal 95
shedding could be a useful feature for assaying the levels of overall infection in a community. 96
97
One method that has been proposed for use in monitoring population-level rates of SARS-CoV-2 98
infection is wastewater-based epidemiology (WBE). WBE is the quantitative detection of chemical and 99
biological signatures in wastewater to analyze the status of a human population in an area17. This 100
approach has been used extensively in the past to characterize community usage/prevalence of illicit 101
drugs such as cocaine, amphetamines, and opiates17. WBE detection methods have also been widely used 102
to monitor the trends of circulating human pathogens in wastewater streams around the world17,18. Of 103
particular relevance to SARS-CoV-2 are the efforts centering around environmental surveillance of the 104
enteric viruses Poliovirus, Hepatitis A, and Norovirus19-21 105
106
In the Spring of 2020, research groups around the world started reporting the detection of SARS-CoV-2 107
RNA in untreated wastewater22-25 using quantitative reverse transcription PCR (RT-qPCR). SARS-CoV-2 108
RNA levels in wastewater positively correlated with clinical COVID-19 case numbers22. Several studies 109
were able to demonstrate that an increasing trend of SARS-CoV-2 in wastewater preceded a rise in 110
clinical cases by up to one week25-27, establishing the potential utility of COVID-19 WBE as an “early 111
warning system” to mitigate viral spread and cost effective strategy for monitoring real-time changes in 112
viral prevalence. 113
114
As viral concentrations in wastewater tend to be low, sample concentration is often a pre-requisite for 115
sensitive detection and accurate quantitation. Concentration of viral matter can be performed using a 116
variety of methods such as charged membrane filtration, centrifugal ultrafiltration, 117
flocculation/precipitation using skimmed milk, and polyethylene glycol (PEG)/NaCl precipitation28. Most 118
of the viral concentration methods described in the literature were originally developed to concentrate 119
non-enveloped viral particles for use in downstream culture-based approaches, but they have been also 120
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
5
used for PCR detection. Many of these methods may work efficiently with several virus types but present 121
difficulties when applied to SARS-CoV-2. Notable issues have included inconsistent rates of viral 122
recovery after concentration, requirement for large sample sizes, and co-purification of PCR 123
inhibitors29,30. In addition, these viral concentration methods are labor intensive and time consuming, 124
requiring separate viral concentration and a nucleic acid extraction steps. 125
126
In this report, we describe the use of a novel column-based viral concentration and nucleic acid 127
purification system coupled to RT-qPCR detection for monitoring SARS-CoV-2 levels in wastewater. 128
The system allows for increased sample throughput due to the combination of viral purification and 129
nucleic acid purification steps. The effect of PCR inhibitors commonly found in wastewater is also 130
minimized. To demonstrate proof-of-concept, wastewater from three communities in Dane County, 131
Wisconsin was monitored for the presence of SARS-CoV-2 RNA over the course of three months. We 132
also successfully sequenced from a subset of samples to show compatibility with a commercially 133
available SARS-CoV-2 amplicon panel and demonstrated the potential for SARS-CoV-2 variant detection 134
from wastewater nucleic acid purified with the direct capture method. 135
136
137
Methods
138
139
Sample collection 140
Wastewater (untreated primary effluent) was collected from three wastewater treatment plants in Dane 141
County, Wisconsin: Oregon (WWTP-1), Madison (WWTP-2), Sun Prairie (WWTP-3). In all three 142
communities, the wastewater collection system is separate from the storm sewer system, minimizing the 143
dilution effect of precipitation events. 500-1000mL of a flow-paced (Oregon, Sun Prairie) or time-paced 144
(Madison) 24-hour composite sample were collected weekly using an autosampler (Madison: ISCO 145
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
6
FR3710; Sun Prairie: ISCO 5800; Oregon: ISCO 4700). Samples were kept at 4°C at all times during 146
transport and storage. All samples were processed within six hours of sampling. 147
148
MS2 (ATCC 15597-B1) and Escherichia coli ATCC 15597 were purchased from American Type Culture 149
Collection (ATCC) and propagated based on published methods31. The viral fraction in the culture 150
supernatant was collected by centrifuging at 3500 x g for 30 minutes to remove the bacterial fraction and 151
filtered through a 0.22 μm PES membrane filter. The purified MS2 virus (∼107 PFU mL–1) was stored at 152
4 °C. MS2 virus was spiked in wastewater samples to final concentrations of 4 × 104 PFU mL–1. Samples 153
were then briefly mixed and nucleic acid extracted as described below. 154
155
Isolation of Total Nucleic Acid from wastewater using the direct capture method 156
Total nucleic acid (TNA) was purified from collected wastewater using the Wizard® Enviro Wastewater 157
TNA kit (Promega Corp.) and/or the Maxwell® Enviro Wastewater TNA kit (Promega Corp.), both of 158
which use an initial concentration step composed of direct capture of nucleic acids on silica resin. Briefly, 159
0.5 mL of alkaline protease was added to 40 mL of untreated wastewater in triplicate, and samples were 160
incubated statically for 30 minutes at room temperature. The samples were then centrifuged at 3000 x g 161
for 10 minutes to remove suspended solids. The supernatant was transferred to a new vessel and 12 mL of 162
Binding Buffer 1 and 1 mL of Binding Buffer 2 were added, followed by gentle mixing. A 48 mL of 163
isopropanol was added to the mixture, gently mixed and passed through a PureYield™ Midi Binding 164
Column (Promega Corp.) using a VacMan® Vacuum Manifold (Promega Corp.). Nucleic acid captured on 165
the PureYield™ Midi Binding Column was washed with 5 mL of Column Wash 1 followed by 20 mL of 166
Column Wash 2. Nucleic acid was eluted with nuclease-free water (Fig. 2). 167
168
The eluted nucleic acid was further purified using a Mini spin column for the Wizard® Enviro Wastewater 169
TNA kit or with an automated nucleic acid purification system (Maxwell® RSC, Promega Corp) for the 170
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
7
Maxwell® Enviro Wastewater TNA kit (Fig. 2). For the manual Wizard® Enviro Wastewater TNA kit, 171
400 µL of Binding Buffer 1, 100 µL of Binding Buffer 2 and 1.5 mL of isopropanol are added to the 1 172
mL of nucleic acid extracted in the concentration step, and then passed through a spin column with a 173
silica resin. The column is washed with 350µL and 1 ml of Column Wash 1 and 2 respectively, and 174
nucleic acid is extracted in 80 µL of water. For the automated Maxwell® Enviro Wastewater TNA kit , 175
150 µL of Binding Buffer 1 and 50 µL of Binding Buffer 2 are added to 0.5 mL of nucleic acid extracted 176
in the concentration step. Then the total volume is added to well #1 of the Maxwell® Cartridge and 177
nucleic acid is eluted in 80 µL of nuclease-free water. 178
179
180
Isolation of Total Nucleic Acid from suspended solids using the direct capture method 181
The method to extract total nucleic acids from suspended solids is a variation on the direct capture 182
methodology described above. After the alkaline protease step, the pellet of suspended solids is 183
resuspended in 5 mL of nuclease-free water. To the resuspended pellet, 1.5 mL of Binding Buffer 1, 125 184
μL of Binding Buffer 2 and 6 mL of isopropanol were added and mixed. This step releases the nucleic 185
acid bound to the solids into the suspension. The mixture was centrifuged at 3,000 x g for 10 minutes. 186
The supernatant contains the nucleic acid from the solids. The supernatant is then added to the 187
PureYield™ Midi Binding Column for the respective sample and treated independently as described 188
above. 189
190
PEG/NaCl precipitation 191
A sample of 120 mL of wastewater was centrifuged at 3000 x g for 30 minutes to pellet any particulate 192
material. The supernatant was carefully decanted and then mixed with 12 g of PEG 8000 and 2.7 g of 193
NaCl that were dissolved by gentle mixing. Samples were then centrifuged at 11,400 x g for two hours to 194
pellet viral material. The supernatant was carefully removed via pipetting on the side of the tube opposite 195
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
8
of that which the pellet was formed (pellet was not visible). The pellets were resuspended by vortexing 196
with residual supernatant to a final volume of approximately 200 µL. Further nucleic acid purification 197
was performed using Maxwell® RSC PureFood GMO and Authentication Kit (Promega Corp.) using the 198
Maxwell® RSC Instrument (Promega Corp.) according to a modified version of manufacturer’s protocol. 199
Briefly, to 200μl of wastewater concentrate, 200 μL of CTAB and 40 μL of Proteinase K were added. 200
Samples were vortexed, then incubated at 56°C for 10 minutes. The entire sample volume and 300 μL of 201
Lysis Buffer were added to well #1 of the Maxwell® RSC cartridge. Nucleic acid was eluted with 50 μL 202
of Elution Buffer. Samples were processed on the Maxwell® RSC with the PureFood GMO and 203
Authentication method. 204
205
Oligonucleotides and quantification standards 206
Table S1 lists the primers and probes used in this study, including primer and probe sets for the detection 207
of SARS-CoV-2 (CDC-N1, CDC-N2, E_Sarbeco), PMMoV, and MS2 bacteriophage. The primers and 208
probe for amplifying the luciferase (luc) gene for the internal amplification control are also listed. 209
210
The SARS-CoV-2 quantification standard was created by inserting the envelope gene (NCBI: 43740570) 211
and the nucleocapsid gene (NCBI: 43740575) of SARS-CoV-2 into the pGEM-3z vector (Promega 212
Corp.) using the BamH I site. The plasmid was subsequently linearized using Xba I. The linearized 213
plasmid was in-vitro transcribed using T7 RiboMAX™ Large Scale RNA Production System (Promega 214
Corp.) to create Positive Control RNA. The linearized plasmid DNA containing the N and E genes, or the 215
in-vitro transcribed RNA were quantified using droplet digital PCR and used as a quantification control. 216
Linear quantification DNA and positive control RNA for PMMoV and MS2 were generated and 217
quantified using the same methods described above. 218
219
220
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
9
RT-qPCR and quantification of viral load in wastewater 221
TNA isolated from wastewater was used to perform RT-qPCR using the SARS-CoV-2 RT-qPCR 222
Detection Kit for Wastewater (Promega Corp.). RT-qPCR reactions targeted the nucleocapsid (N1, N2) 223
and envelope (E) regions of the SARS-CoV-2 genome. To allow for quantitation, log dilutions (2x101 – 224
2x105 Genome Units (GU)/µL) of DNA quantitation standard were amplified alongside experimental 225
samples and used to construct a standard curve for each SARS-CoV-2 target. 20 µL amplification 226
reactions were composed of 15 µL reaction mastermix and 5uL of nucleic acid. 5 µL of nuclease-free 227
water was used as a no-template-control (NTC). Reactions were performed on a Stratagene MX3005 228
Real-Time Thermocycler (Agilent) with the following cycling conditions: reverse transcription for 15 229
minutes at 45°C, initial denaturation for 2 minutes at 95°C, and 40 cycles of 3 seconds at 95°C and 30 230
seconds at 62°C. Standard curve reactions were run in triplicate and wastewater sample reactions were 231
run in duplicate. The standard curve approach described above was used in parallel to estimate the 232
concentration of MS2 and PMMoV in purified samples. 233
234
Concentration of viral load in wastewater was calculated using the equation: 235
236
237
238
239
240
Normalization of SARS CoV-2 amounts in wastewater was performed by using the following equation: 241
242
243
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
10
Statistical analysis 244
Concordance between trend analysis using the three SARS-CoV-2 targets (N1, N2 and E) was evaluated 245
using Kendall’s coefficient of concordance (W). Correlation between weekly normalized SARS-CoV-2 246
levels from wastewater and number of new clinical cases (7 day moving average) was determined using 247
Kendall’s tau correlation coefficient. 248
249
SARS-CoV-2 amplicon library preparation and sequencing 250
10 µL of each total nucleic acid sample was treated for 30 minutes at 37°C with 1.5 U of RQ1 RNase-251
Free DNase (Promega Corporation) in a 15 µL reaction, as specified in the manufacturer’s protocol, 252
except that the Stop Solution provided was not used. 10 µL of nuclease-free water was added to each 253
sample and cleaned up with the ReliaPrep™ RNA Clean-Up and Concentration System (Promega 254
Corporation), as specified in the manufacturer’s technical manual. RNA was eluted with 15 µL of 255
nuclease-free water. 256
257
cDNA was synthesized as follows. 10 µL of either total nucleic acid sample or DNase-treated sample was 258
used as a template for first strand synthesis with random hexamers and associated steps using 259
Invitrogen™ SuperScript™ IV First-Strand Synthesis System (Thermo Fisher Scientific). Manufacturer’s 260
instructions were followed with one exception: incubation time at 50°C was increased from 10 minutes to 261
30 minutes, as recommended by the Swift Biosciences SARS-CoV-2 Additional Genome Coverage 262
amplicon panel library preparation protocol. 263
264
10 µL of cDNA was used as input for the SARS-CoV-2 Additional Genome Coverage panel (Swift 265
Biosciences) using the low input version of the library preparation protocol. This 345-amplicon panel 266
covers 99.7% of the SARS-CoV-2 genome and has amplicons ranging from 116 to 255 bp (average 150 267
bp). Libraries were quantified by qPCR, pooled, and sequenced with 2 x 150 base-pair reads on an 268
Illumina MiniSeq Instrument with a MiniSeq Mid Output Kit (300-cycles). 269
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
11
270
Amplicon sequencing analysis 271
Compressed, demultiplexed reads were obtained from the Illumina MiniSeq instrument and assessed for 272
sequencing quality using FastQC 0.11.9-0 273
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). For the purpose of comparing 274
performance between libraries, random subsampling was performed to obtain the same number of input 275
reads for each library using seqtk v1.2. All available reads for each library were used in known variant 276
detection. Adapter trimming was done using Fastp v0.20.132 (sequences 277
AGATCGGAAGAGCACACGTCTGAACTCCAGTCA and 278
AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT). Trimmed reads were mapped to the SARS-279
CoV-2 reference genome (NC_045512.2) using BWA v 0.7.17. To assess human genomic contribution, 280
trimmed reads were also mapped to a combined SARS-CoV-2 + GRCh38/hg3833 (UCSC Genome 281
Browser34 Dec 2013 assembly) reference genome. Amplicon primers were trimmed following alignment 282
using Swift’s Primerclip tool v 0.3.8 (https://github.com/swiftbiosciences/primerclip) with the Swift-283
provided master file for the 345 amplicon panel as input. QC metrics were generated using Picard (v 284
2.9.2; http://broadinstitute.github.io/picard) BedToIntervalList, CollectTargetedPcrMetrics, 285
CollectGcBiasMetrics. The GATK335 DepthOfCoverage tool was used for target base coverage 286
assessments (median, mean, percent of bases at or above 1X, 100X, 1000X, and 5000X). Snakemake 287
v5.17.0 was used for workflow management on a Microsoft Azure CycleCloud instance. 288
289
Detection of known signature variants 290
Genomic locations of known signature variants were obtained from Nextstrain36 (accessed 12 March 291
2021) and UCSC Table Browser37 (SARS-CoV-2 Jan. 2020/NC_045512.2 Assembly (wuhCor1)) and 292
formatted into a BED file. With aligned, primer-trimmed reads in BAM format, the bam-readcount tool 293
(https://github.com/genome/bam-readcount) was used to collect base composition information at the 294
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
12
signature variant locations. The bam-readcount output was filtered to look for the presence of signature 295
variants with at least 10% frequency at positions covered to at least 50X, so that no signature variant 296
would be called as detected with fewer than 5 sequencing reads as evidence. 297
298
Results
299
300
RT-qPCR Reaction Formulation and Setup 301
Operating under the assumption that wastewater is likely to contain RT-qPCR inhibitors, we formulated 302
enzyme mixes containing MMLV-RT enzyme and Taq DNA polymerase (with hot-start chemistry) that 303
would be resistant to PCR inhibitors. Next, we designed separate multiplexed RT-qPCR assays to detect 304
the nucleocapsid gene fragment N1 and N2 (as described by the CDC: 305
https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html) and the envelope gene 306
(as described by Corman et al.38). SARS-CoV-2 targets were detected using primers and a target-specific 307
hydrolysis probes (labeled with 5’ FAM/ZEN™/ 3’ Iowa Black™ FQ). Each assay was multiplexed with 308
primers and a hydrolysis probe (labeled with 5’ Quasar®670/ BHQ®-2) complementary for Pepper Mild 309
Mottle Virus (PMMoV). PMMoV is a single-stranded RNA plant virus that commonly infects pepper 310
products intended for human consumption39. PMMoV RNA is detectable in wastewater worldwide and is 311
considered an important indicator of human-derived fecal pollution40-42. Each assay also includes an 312
exogenous RNA template, primers and hydrolysis probe (labeled with 5’ CalFluor® Orange 560/ BHQ®-1) 313
comprising an internal amplification control (IAC). The IAC’s cycle threshold (Ct) provides information 314
on the presence of reverse transcriptase and DNA polymerase inhibitors in the extracted nucleic acid 315
sample. CXR, (Carboxy-X-Rhodamine, Promega Corp.) which has similar spectral properties as ROX 316
(Ex: 580nm, Em: 602nm) was used as a reference dye. 317
318
We sought to optimize an appropriate amplicon length from the IAC template to provide sufficient 319
sensitivity to detect RT-qPCR inhibition. An in vitro transcribed Luciferase RNA (Promega Corp .) was 320
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
13
used as a template and four different amplicon lengths (93 bp, 285 bp, 310 bp and 435bp) were tested. 321
Humic acid, a known reverse transcriptase and DNA polymerase inhibitor 43, was titrated from 0 µg/mL 322
to 125 µg/mL using a two-fold dilution series, and inhibition was assessed by the difference in Ct value 323
with or without humic acid (Ct). The same hydrolysis probe was used in all cases. As expected, we 324
found a correlation between the amplicon length and sensitivity to humic acid (Fig . 1A), with the 435 bp 325
and 315 bp amplicons exhibiting higher ΔCt values compared to the 285 bp and 93 bp amplicons. Since 326
the RT-qPCR amplicons for detection of SARS-CoV-2 and PMMoV are below 150 bp in length and the 327
ΔCt values for 285bp and 93bp amplicons were similar, the 285 bp amplicon length was used as IAC 328
unless otherwise specified. 329
330
For WBE, it is important to quantify the viral genome units per volume of wastewater to determine the 331
quantitative trend in viral load. To analyze the analytical sensitivity, efficiency, and linearity of the assay, 332
a log dilution series of the in-vitro transcribed SARS-CoV-2 RNA (N and E) was used to perform RT-333
qPCR analysis. PCR amplification efficiencies for all three targets were between 90-120%. The limit of 334
detection (LOD95) for the three multiplexed assays for detecting the SARS-CoV-2 targets was 5 copies 335
and a limit of quantification (LOQ) of 8 copies. The RT-qPCR assays are linear in the tested range of 20-336
200,0000 copies, as the observed R2 for all the three targets were ≥ 0.99 (Fig. 1B). 337
The assay was also tested for specificity with other coronaviruses and respiratory pathogens. The assay 338
was found to be specific for detection of SARS-CoV-2 and PMMoV (Table S2). 339
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
14
340
Figure 1. (A) Optimization of Internal Amplification Control (IAC) amplicon size for 341
indication of inhibitor tolerance. Amplification of luc in-vitro transcribed RNA 342
template of listed amplicon sizes was performed with different humic acid 343
concentrations present in the RT-qPCR reaction. (B) Performance characteristics of the 344
three multiplexed RT-qPCR assays for detection of SARS-CoV-2 in wastewater. Standard 345
curve reactions were performed in triplicate. 346
347
Description of the direct-nucleic acid capture method 348
Existing literature suggests that SARS-CoV-2 may not be infectious in wastewater samples44,45. It is 349
therefore unknown if the viral genetic signature present in the wastewater samples is entirely derived 350
from compromised virions or if some proportion is present as unpackaged SARS-CoV-2 nucleic acid. We 351
hypothesized that by utilizing a direct capture method to bind total nucleic acid (TNA) to a silica-based 352
affinity resin in place of a method that is selective for intact viral particles, we may be able to eliminate 353
the viral concentration step which is often a cause of technical variability and low recovery. Direct TNA 354
isolation would be unbiased toward intact, partially intact, or free viral RNA. We developed a simple, 355
rapid, highly efficient, and modular alternative to existing wastewater RNA purification methods. The 356
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
15
primary concentration method utilizes raw sewage, to which chaotropic agents are added to allow binding 357
on to a silica matrix (PureYield™ Midi Binding column) by applying vacuum. The captured nucleic acid 358
is then subjected to successive alcohol washes (to remove RT-qPCR inhibitors that may have co-purified 359
with the nucleic acid) and subsequently eluted in water (Fig. 2). The eluted nucleic acid can then be 360
further processed in a second step with either a spin column with Wizard® Enviro Wastewater TNA kit or 361
with an automated nucleic acid purification system for the Maxwell® RSC Enviro Wastewater TNA kit 362
(Fig. 2). 363
364
Figure 2. Schematic overview of the direct capture nucleic acid purification process. 365
366
The direct-nucleic acid capture method was first tested for its ability to eliminate RT-qPCR inhibitors. 367
Inhibition was analyzed by comparing the difference in Ct value (ΔCt) between IAC amplification in 368
reactions for wastewater sample and for no-template-control (NTC) reactions. The ΔCt values were 369
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
16
analyzed for samples processed using either the primary concentration step with the PureYield™ Midi 370
column only or processed through the complete workflow comprising the Wizard® 371
concentration/purification steps outlined above. ΔCt values > 1 indicated the presence of reverse 372
transcriptase and/or DNA polymerase inhibitors in the wastewater samples added to the RT-qPCR 373
reaction. ΔCt values of <1 were observed for both nucleic acid purified with the PureYield™ Midi 374
column only and samples purified with both ™ Midi and PureYield™ Mini column steps (Fig. 3A). In the 375
second step, total nucleic acid eluted from the first step is further purified in a smaller volume (80 µL), 376
concentrating the nucleic acid by 12.5-fold. This concentration is evident when MS2 (viral spike-in 377
control) or SARS-CoV-2 (N1) is analyzed, as we observed a 8.34- and 5.54- fold increase in the amount 378
of MS2 and SARS-CoV-2 RNA detected, relative to the sample that only underwent initial sample 379
concentration (Fig. 3B and C). This indicates that the second purification step successfully concentrates 380
the nucleic acid in the sample. 381
Different laboratories have different throughput needs. Because our workflow can be done manually or 382
using automation for the final sample concentration, it provides flexibility for different types of labs. This 383
flexibility allows scale-up of the nucleic acid concentration process using an automated nucleic acid 384
purification workflow after the initial concentration step using the PureYield™ Midi column. We 385
compared the extraction efficiency of the nucleic acid isolated by either the manual spin column (Wizard® 386
Enviro Wastewater TNA kit) or with an automated nucleic acid purification system for the Maxwell® 387
RSC Enviro Wastewater TNA kit. Purified concentrations of PMMoV, MS2 (viral spike), and SARS-388
CoV-2 RNA were similar with both purification methods (Fig. 3D). These data indicate that both manual 389
and automated nucleic acid purification procedures can be used to extract viral genetic material at similar 390
extraction efficiencies. 391
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
17
392
Figure 3. (A) The direct capture method can reduce presence of RT-qPCR inhibitors 393
present in extracted samples. “Full workflow” refers to the combination of 394
concentration and purification steps shown in Fig. 2. ΔCt is defined as the 395
difference in internal amplification control (IAC) amplification (Ct Value) between 396
the NTC wells compared to sample wells. Viral concentrations detected via RT-qPCR 397
using listed workflows for (B) MS2 phage (viral wastewater spike) and (C) SARS CoV-2. 398
(D) The extraction efficiencies of the purification step performed using the Wizard 399
spin column or Maxwell automated instrument are similar for the extraction of PMMoV, 400
MS2 and SARS-CoV-2. Results shown are means ± SD (n= 3) 401
402
Sample volume considerations 403
SARS-CoV-2 levels in wastewater are often very low, making sample concentration from a larger volume 404
a necessary part of any WBE monitoring workflow. To determine what starting sample volume allows for 405
convenient and sensitive viral detection, we processed different volumes of wastewater (80 mL, 40 mL, 406
20 mL, 10 mL, and 5 mL) using the column-based manual concentration/purification scheme (Wizard®) 407
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
18
outlined above and performed all final elutions in the same volume (80 µL) of nuclease-free water. The 408
adjusted volumes of Protease solution, binding buffers 1 and 2 and isopropanol used for each starting 409
volume are outlined in Fig. 4A. MS2 bacteriophage was used as a viral spike-in recovery control. 410
The shift in Ct values from the NTC reactions (ΔCt) for the IAC exhibited a sample volume-dependent 411
increase in Ct value indicating a higher concentration of inhibitors may be co-purifying when larger 412
volumes are used. However, the ΔCt was <1 Ct for all the volumes tested, indicating co-purification of 413
RT-PCR inhibitors was not high enough to significantly impact data interpretation (Fig 4B). We also 414
analyzed the amounts of PMMoV, MS2 and SARS-CoV-2 (N1). As expected, all targets showed a 415
volume-dependent enrichment of genetic material. (Fig 4C-E). Though we can accurately detect SARS-416
CoV-2 signal from 5 ml of sample during the current sampling period when SARS-CoV-2 clinical cases 417
are high, use of 40 ml sample volume will allow sufficient assay sensitivity when viral loads are lower. 418
419
420
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
19
Figure 4. Sample volume considerations. (A) Volumes of reagents required for different 421
sample volumes. (B) Increasing the sample volume from 5 ml to 80 ml does not lead to 422
significant inhibition of RT-qPCR performance as measured using the Internal 423
amplification control (IAC). DCt represents the difference in Ct values of samples 424
compared to the NTC reactions. (C-E) Increase in the amount of viral genetic material 425
extracted as sample volume is increased as measured by RT-qPCR detection of PMMoV (C), 426
MS2 (D) and SARS-CoV-2 (E). Extraction efficiency of MS2 (F) and SARS-CoV-2 (G) 427
genetic material from wastewater samples with and without protease treatment. Results 428
shown are means ± SD (n= 3). 429
430
Enhancement of viral nucleic acid recovery with protease treatment 431
Wastewater, in addition to containing fecal matter and water, is also composed of cellulosic material from 432
toilet and tissue paper that may act as a substrate on which nucleic acids and nucleoprotein complexes can 433
aggregate. This material may form a large part of the suspended solids present in wastewater. SARS-434
CoV-2 may not be present as intact virions in wastewater, but the observation that the genetic material is 435
readily detectable indicates that the viral RNA is likely present in ribonucleoprotein complexes, which 436
shield it from nucleases that are presumably present in wastewater. In addition, detergents and chaotropic 437
agents present in wastewater may also cause structural changes to proteins causing association with 438
suspended solids. Therefore, we reasoned that a proteolytic cleavage step may be able to release some of 439
the viral genetic material associated with solids. 440
We measured viral nucleic acid extraction efficiency using a procedure that included alkaline protease 441
treatment. 40 mL wastewater samples were either treated with alkaline protease or left untreated and 442
processed as described in the Methods section. MS2 phage was also spiked into the samples. Percent 443
recoveries of MS2 nucleic acid were found to be 20% for untreated samples and 40% for samples that 444
were treated with alkaline protease (Fig. 4F). Similarly, we also observed a two-fold increase in 445
extraction of SARS-CoV-2 viral genome units when samples were treated with protease (Fig. 4G). These 446
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
20
Results
indicate that alkaline protease treatment increases yield of viral TNA extraction, most likely by 447
releasing a portion of the viral genomic material associated with suspended solids. 448
449
Amount of viral matter associated with solids 450
In the purification workflow described above, suspended solids are removed via a brief centrifugation 451
following the alkaline protease treatment step. Removing suspended solids prevents clogging of the 452
PureYield™ Midi column. We investigated how much viral matter is associated with the pelleted solids 453
using the procedure described in the methods section. The eluted nucleic acid was analyzed for the 454
quantity of PMMoV and SARS-CoV-2 RNA. We observed that about 11.79% of the total amount of 455
PMMoV and 19.27% of the total amount of SARS-CoV-2 genetic material associated with the solids 456
(Fig. 5A-B). If maximal nucleic acid yield is desired, the solids-associated supernatant fraction can be 457
combined with the wastewater supernatant fraction to purify nucleic acid from the total pooled sample. 458
459
Figure 5. Amount of viral matter associated with solids after protease treatment. 460
Wastewater samples were centrifuged after protease treatment and resulting solids and 461
suspension fractions were processed as described in the Methods section. 462
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
21
Concentrations of PMMoV (A) and SARS-CoV-2 (B) RNA present in the two fractions as 463
measured by RT-qPCR are shown. Results shown are means ± SD (n= 3). 464
465
Comparison of viral nucleic acid recovery: Direct Capture method vs PEG/NaCl precipitation 466
Using the optimized method described above, we compared the direct capture method with PEG/NaCl 467
precipitation method for the ability to purify SARS-CoV-2 genetic material from wastewater samples. 468
PEG/NaCl is a widely used method for precipitation and concentration of non-enveloped enteric virus 469
such as Poliovirus28. 40 mL of wastewater sample was processed for the direct capture method and 120 470
mL of wastewater was processed using PEG/NaCl precipitation. We observed a 20-fold increased 471
extraction efficiency for extracting SARS-CoV-2 RNA (Fig. 6A) when using the direct capture method 472
compared to the PEG/NaCl protocol. For MS2 (viral spike control) we observed an extraction efficiency 473
of 3.76 ± 1.88% for the PEG/NaCl method and 39.67 ± 10.66% for the direct capture method (Fig 6B). 474
We also determined the percentage recovery for two human coronaviruses (OC43 and 229E) for the direct 475
capture method and they were 63.13 ± 4.16%, 40.09 ± 10.89% respectively (data not shown). 476
The direct capture purification workflow utilizing 40 ml of wastewater sample and a 40ul elution volume 477
has a concentration factor of 1000. With a LOD of 5 copies for the detection of SARS-CoV-2 by RT-478
qPCR reaction, and 1000-fold concentration in the purification process, the assay sensitivity is around 1 479
viral genome copies/ml. This level of sensitivity will be sufficient for trend analysis using WBE. 480
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
22
481
Figure 6. Comparison of the direct capture method with PEG/NaCl precipitation. 482
Wastewater samples were processed using the two methods as described in the Methods 483
section. (A) Concentration of SARS-CoV-2 RNA extracted is represented as GU/L in the 484
wastewater sample, (B) Percentage recovery for extraction of MS2 phage (viral spike 485
control). Results shown are means ± SD (n= 3). 486
487
SARS-CoV-2 RNA in wastewater from Dane County, Wisconsin 488
The levels of SARS-CoV-2 RNA from three wastewater treatment plants in Dane County, Wisconsin 489
from mid-October, 2020 to early January, 2021 were determined using the Wizard® Enviro Wastewater 490
TNA kit described above. Samples were processed and analyzed weekly. The levels of RT-qPCR 491
inhibitors present in the TNA samples (as assessed by shift in the Ct value (Ct) of IAC in sample wells 492
compared to NTC wells) were not notable, as Ct values were less than 0.5 for all wastewater samples 493
(Fig. 7A). 494
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
23
We analyzed SARS-CoV-2 RNA levels using N1, N2, and E targets (Fig. 7B). All samples were positive 495
for all three SARS-CoV-2 targets within the period tested. We calculated the degree of concordance 496
between the three SARS-CoV-2 targets for the three WWTPs over the sampling period using Kendall's 497
coefficient of concordance, W. Kendall's W ranges from 0 (no agreement) to 1 (full agreement). We 498
observed statistically significant concordance between the three SARS-CoV-2 targets for the three 499
WWTPs (W=0.97 for WWTP-1, W=0.96 for WWTP-2 and W=0.78 for WWTP-3). 500
WWTP-1 served a small community of around 10,000 people. We normalized SARS-CoV-2 levels with 501
PMMoV, which has been proposed to account for differential dilution and degradation rates over time. 502
We compared SARS-CoV-2 RNA signals in wastewater to the level of COVID-19 cases (7-day moving 503
average) declared by the municipality and analyzed the correlation between the two, resulting in a 504
Kendall’s Tau coefficient of 0.33, with a p-value of 0.08 (Fig 7C). The peak of SARS-CoV-2 genetic 505
signal observed in the wastewater is concurrent with the peak of positive SARS-CoV-2 reported in mid-506
November of 2020. Even with this limited data set we see the potential for wastewater-based surveillance 507
in assessing community-wide spread of the disease. 508
509
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
24
Figure 7. WBE analyses of samples from three wastewater treatment plants in Dane 510
County, WI. (A) Assessment of PCR inhibitors in nucleic acid isolated from the three 511
WWTP. Results shown are means ± SD (n> 30). (B) Levels of SARS-CoV-2 analyzed over the 512
indicated duration with three SARS-CoV-2 targets (N1, N2, E) for the three WWTP. 513
Results
shown are means ± SD (n= 3). (C) Comparison of the normalized SARS-CoV-2 RNA 514
levels with the 7-day moving average of the new reported cases for the community 515
serving WWTP-1. 516
517
Amplicon sequencing of SARS-CoV-2 genetic material in wastewater 518
To determine if our direct capture purification method yielded nucleic acid compatible with next-519
generation sequencing, we prepared sequencing libraries with a subset of wastewater samples using a 520
commercially available SARS-CoV-2 amplicon panel and associated library preparation kit46,47. 521
For this proof of concept, we focused on three samples: wastewater from WWTP-2 in November of 2020 522
and January 2021, as well as wastewater collected from WWTP-3 in December of 2020. Because of the 523
proximity of the two collection sites to one another, we reasoned that these samples could be compared 524
broadly for the purpose of identifying SARS-CoV-2 variants, while also demonstrating the robustness of 525
the method to different wastewater treatment regimens from different facilities. 526
We compared total nucleic acid or DNase-treated nucleic acid as input into the library preparation 527
workflow. Most libraries had greater than 1 million reads, but for comparison of depth metrics, the total 528
number of reads was normalized across libraries by randomly subsampling to 650,000 total paired reads. 529
We aligned the subsampled, filtered sequencing reads to the SARS-CoV-2 genome and measured the 530
percentage of filtered reads aligned and the depth of coverage across amplicons tiling the SARS-CoV-2 531
genome (Fig. 8A-B). Samples that were DNase-treated had higher percentage of filtered reads aligning to 532
the SARS-CoV-2 genome and greater depth of coverage compared to total nucleic acid libraries. Because 533
wastewater is a heterogeneous sample, it is not surprising that the amplification reaction resulted in off-534
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
25
target amplification. This data shows that DNase treatment of wastewater total nucleic acid improves 535
next-generation sequencing quality from the SARS-CoV-2 amplicon panel tested. 536
We aligned the reads a second time to a combined reference genome containing both SARS-CoV-2 and 537
human reference genomes to examine the proportion of aligned, filtered reads attributable to 538
contamination by human genetic material. Surprisingly, we found that the percentage of filtered reads 539
aligning to the human genome increased after DNase treatment (3.5%-9.4% for total nucleic acid and 540
6.3%-16.5% for DNase-treated samples). However, the proportion of non-human contamination reduced 541
by DNase treatment makes this the preferred protocol. 542
Finally, using all available reads, we analyzed the aligned sequencing reads from the DNase-treated 543
samples to look for the presence of previously reported SARS-CoV-2 variants of concern associated with 544
widespread viral strains. The variants that we detected (Supplemental file 1) were consistent with known 545
variants in Dane County, Wisconsin during the sampling period36. Virtually all the SARS-CoV-2 546
sequences contained mutations corresponding to Nextstrain clade 20A. Mutations found in Nextstrain 547
clades 20B, 20C, and 20G were also present, though mutations specific to strain 20B were present at 548
2.0% frequency in January, below the 10% frequency cutoff we had set for making a positive call. 549
Although merely suggestive due to small sample size, this does correspond to Nextstrain reported data 550
which also suggests a decrease in the prevalence of this strain over the sampling period. More 551
transmissible strains were not observed in this data, consistent with Nextstrain reports for such strains 552
initially appearing in this geographic area approximately 2 months after the sampling period. 553
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
26
554
Figure 8. Analysis of wastewater nucleic acid for SARS-CoV-2 sequencing. Nucleic acid 555
from the three wastewater collection sites and a pooled sample from the three 556
collection sites at the indicated timepoints was used to generate SARS-CoV-2 amplicon 557
libraries. Each dataset was randomly subsampled to 650,000 reads for comparison. (A) 558
Percent of filtered reads aligned to SARS-CoV-2 genome for DNase-treated samples (+ 559
DNase) or untreated total nucleic acid samples (- DNase). (B) Percent of target bases 560
on the SARS-CoV-2 genome covered at or above indicated depths. 561
562
Conclusion
563
In this study, we describe a convenient, high throughput, robust, and consistent method to directly 564
capture, concentrate, and detect total nucleic acids (TNA) from wastewater using silica based PureYield® 565
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
27
columns and optimized RT-qPCR. This method offers ease-of-use and minimizes the need for specialized 566
laboratory equipment. In addition, the method achieves consistent recovery rates and significant reduction 567
in RT-qPCR inhibitors. 568
During the course of this study, alternative direct capture methods for extraction of SARS-CoV-2 RNA 569
from wastewater have been published, highlighting the simplicity of the general workflow48. Direct 570
capture methods have also been applied in large-scale interlaboratory method assessment studies where 571
they have shown superior and consistent performance over other methods including PEG/NaCl 572
precipitation, centrifugal ultrafiltration, or charged membranes49. By using a protease treatment step, we 573
are able to release a significant portion of viral nucleic acid associated with the solids in the wastewater. 574
In addition, chaotropes and alcohols provide an effective nucleic acid binding environment for capture on 575
a silica matrix. The two-step, modular purification strategy described in this work simplifies the 576
workflow for users processing either small or large amounts of wastewater samples. The flexibility of the 577
Method
and compatibility of the resulting nucleic acid with downstream analysis by RT-qPCR and 578
SARS-CoV-2 sequencing allow for straightforward adoption for WBE-based viral surveillance 579
approaches. 580
Throughout the early course of the COVID-19 pandemic, the ramifications of not having nationwide 581
surveillance systems in place were observed. WBE and clinical diagnostic testing each can provide 582
structured surveillance systems. WBE can complement clinical diagnostic testing by independently 583
confirming prevalence of disease communities and possibly providing an early warning for future viral 584
outbreaks. WBE also provides a low-cost tool to understand community spread in low resource areas. 585
Similar to diagnostic clinical testing, WBE has experimental limitations (uncertainties related to timing 586
and quantities of viral and viral nucleic acid shedding, RNA stability, effect of temperature, and sample 587
processing techniques) that need to be well understood before using acquired data to inform 588
epidemiological and public health efforts around the globe. 589
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
28
As the COVID-19 pandemic has progressed, SARS-CoV-2 genetic variants have arisen, often leading to 590
increased transmissibility, concern about immune evasion, and subsequent outbreaks50. With the 591
emergence of new strains, it will be informative to see how this rapidly evolving method is able to help 592
understand the spread of variants within communities and guide health authorities to take appropriate 593
measures51-53. 594
595
Data Statement 596
Sequencing data are available upon request of the corresponding author. 597
Acknowledgements
598
Amplicon library preparation guidance, basic analysis guidance, and MiniSeq sequencing were provided 599
by Swift Biosciences, Inc (https://swiftbiosci.com). We thank Paul Muschler for providing valuable 600
feedback. We acknowledge the staff of Madison Metropolitan Sewage District (MMSD), Village of 601
Oregon, WI and City of Sun Prairie, WI for their support and providing wastewater samples. We also 602
thank the various research groups, public health, and commercial labs with whom we have had many 603
productive discussions on this topic in these difficult times. 604
605
Authorship contribution statement 606
Subhanjan Mondal: Conceptualization, Data curation, Formal analysis, Supervision, Methodology, 607
Investigation, Roles/Writing - original draft, Writing - review & editing. Nathan Feirer: 608
Conceptualization, Data curation Formal analysis, Methodology, Investigation, Roles/Writing - original 609
draft, Writing - review & editing. Michael Brockman: Data curation, Formal analysis, Methodology, 610
Roles/Writing - original draft, Writing - review & editing. Melanie A. Preston: Investigation, Writing - 611
review & editing. Sarah J. Teter: Investigation, Writing - review & editing. Dongping Ma: 612
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
29
Investigation, Said A. Goueli: Resources, Writing - review & editing. Sameer Moorji: 613
Conceptualization, Resources. Brigitta Saul: Conceptualization, Resources. James J. Cali: Resources, 614
Supervision, Writing - review & editing. 615
616
Declaration of competing interest 617
All authors are employed by Promega Corporation. 618
619
References
620
621
1 Zhu, N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 622
382, 727-733, doi:10.1056/NEJMoa2001017 (2020). 623
2 Hartenian, E. et al. The molecular virology of coronaviruses. J Biol Chem 295, 12910-12934, 624
doi:10.1074/jbc.REV120.013930 (2020). 625
3 Cui, J., Li, F. & Shi, Z.-L. Origin and evolution of pathogenic coronaviruses. Nature Reviews 626
Microbiology 17, 181-192, doi:10.1038/s41579-018-0118-9 (2019). 627
4 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. 628
Nature 579, 270-273, doi:10.1038/s41586-020-2012-7 (2020). 629
5 He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 630
26, 672-675, doi:10.1038/s41591-020-0869-5 (2020). 631
6 Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of 632
viral shedding, and infectiousness: a systematic review and meta-analysis. The Lancet Microbe, 633
doi:10.1016/S2666-5247(20)30172-5 (2020). 634
7 Furukawa, N., Brooks, J. & Sobel, J. Evidence Supporting Transmission of Severe Acute 635
Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic. Emerging 636
Infectious Disease journal 26, doi:10.3201/eid2607.201595 (2020). 637
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
30
8 Zhang, Z. et al. Early viral clearance and antibody kinetics of COVID-19 among asymptomatic 638
carriers. 2020.2004.2028.20083139, doi:10.1101/2020.04.28.20083139 %J medRxiv (2020). 639
9 Park, S. K. et al. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic 640
and Mild COVID-19 in Korea. Clin Gastroenterol Hepatol, doi:10.1016/j.cgh.2020.06.005 641
(2020). 642
10 Day, M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in 643
Italian village. 368, m1165, doi:10.1136/bmj.m1165 %J BMJ (2020). 644
11 Wang, W. et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 323, 645
1843-1844, doi:10.1001/jama.2020.3786 %J JAMA (2020). 646
12 Chen, Y. et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med 647
Virol 92, 833-840, doi:10.1002/jmv.25825 (2020). 648
13 Zheng, S. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 649
in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 369, m1443, 650
doi:10.1136/bmj.m1443 (2020). 651
14 Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 652
465-469, doi:10.1038/s41586-020-2196-x (2020). 653
15 Han, M. S. et al. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with 654
COVID-19, Seoul, South Korea. Emerging Infectious Disease journal 26, 2497, 655
doi:10.3201/eid2610.202449 (2020). 656
16 Sethuraman, N., Jeremiah, S. S. & Ryo, A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA 657
323, 2249-2251, doi:10.1001/jama.2020.8259 (2020). 658
17 Lorenzo, M. & Picó, Y. Wastewater-based epidemiology: current status and future prospects. 659
Current Opinion in Environmental Science & Health 9, 77-84, 660
doi:https://doi.org/10.1016/j.coesh.2019.05.007 (2019). 661
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
31
18 Sims, N. & Kasprzyk-Hordern, B. Future perspectives of wastewater-based epidemiology: 662
Monitoring infectious disease spread and resistance to the community level. Environ Int 139, 663
105689, doi:10.1016/j.envint.2020.105689 (2020). 664
19 Hellmer, M. et al. Detection of pathogenic viruses in sewage provided early warnings of hepatitis 665
A virus and norovirus outbreaks. Appl Environ Microbiol 80, 6771-6781, 666
doi:10.1128/AEM.01981-14 (2014). 667
20 Hovi, T. et al. Role of environmental poliovirus surveillance in global polio eradication and 668
beyond. Epidemiol Infect 140, 1-13, doi:10.1017/S095026881000316X (2012). 669
21 Asghar, H. et al. Environmental surveillance for polioviruses in the Global Polio Eradication 670
Initiative. J Infect Dis 210 Suppl 1, S294-303, doi:10.1093/infdis/jiu384 (2014). 671
22 Medema, G., Heijnen, L., Elsinga, G., Italiaander, R. & Brouwer, A. Presence of SARS-672
Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early 673
Stage of the Epidemic in The Netherlands. Environmental Science & Technology Letters, 674
doi:10.1021/acs.estlett.0c00357 (2020). 675
23 La Rosa, G. et al. First detection of SARS-CoV-2 in untreated wastewaters in Italy. Sci Total 676
Environ 736, 139652, doi:10.1016/j.scitotenv.2020.139652 (2020). 677
24 Ahmed, W. et al. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: 678
A proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total 679
Environ 728, 138764, doi:10.1016/j.scitotenv.2020.138764 (2020). 680
25 Peccia, J. et al. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection 681
dynamics. Nature Biotechnology 38, 1164-1167, doi:10.1038/s41587-020-0684-z (2020). 682
26 Randazzo, W. et al. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a 683
low prevalence area. Water Res 181, 115942, doi:10.1016/j.watres.2020.115942 (2020). 684
27 Wurtzer, S. et al. Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral 685
genome quantification in Paris wastewaters. 2020.2004.2012.20062679, 686
doi:10.1101/2020.04.12.20062679 %J medRxiv (2020). 687
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
32
28 Bofill-Mas, S. & Rusiñol, M. Recent trends on methods for the concentration of viruses from 688
water samples. Current Opinion in Environmental Science & Health 16, 7-13, 689
doi:https://doi.org/10.1016/j.coesh.2020.01.006 (2020). 690
29 Ahmed, W. et al. Comparison of virus concentration methods for the RT-qPCR-based recovery of 691
murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater. Sci Total 692
Environ 739, 139960, doi:10.1016/j.scitotenv.2020.139960 (2020). 693
30 Kitajima, M. et al. SARS-CoV-2 in wastewater: State of the knowledge and research needs. 694
Science of The Total Environment 739, 139076, 695
doi:https://doi.org/10.1016/j.scitotenv.2020.139076 (2020). 696
31 Pecson, B. M., Martin, L. V. & Kohn, T. Quantitative PCR for determining the infectivity of 697
bacteriophage MS2 upon inactivation by heat, UV-B radiation, and singlet oxygen: advantages 698
and limitations of an enzymatic treatment to reduce false-positive results. Appl Environ Microbiol 699
75, 5544-5554, doi:10.1128/AEM.00425-09 (2009). 700
32 Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. 701
Bioinformatics 34, i884-i890, doi:10.1093/bioinformatics/bty560 %J Bioinformatics (2018). 702
33 Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921, 703
doi:10.1038/35057062 (2001). 704
34 Kent, W. J. et al. The Human Genome Browser at UCSC. 12, 996-1006, doi:10.1101/gr.229102 705
(2002). 706
35 McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-707
generation DNA sequencing data. 20, 1297-1303, doi:10.1101/gr.107524.110 (2010). 708
36 Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121-709
4123, doi:10.1093/bioinformatics/bty407 (2018). 710
37 Karolchik, D. et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Research 32, 711
D493-D496, doi:10.1093/nar/gkh103 %J Nucleic Acids Research (2004). 712
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
33
38 Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. 713
Euro Surveill 25, doi:10.2807/1560-7917.ES.2020.25.3.2000045 (2020). 714
39 Colson, P. et al. Pepper Mild Mottle Virus, a Plant Virus Associated with Specific Immune 715
Responses, Fever, Abdominal Pains, and Pruritus in Humans. PLOS ONE 5, e10041, 716
doi:10.1371/journal.pone.0010041 (2010). 717
40 Kitajima, M., Sassi, H. P. & Torrey, J. R. Pepper mild mottle virus as a water quality indicator. 718
npj Clean Water 1, 19, doi:10.1038/s41545-018-0019-5 (2018). 719
41 Bivins, A. et al. Cross-assembly phage and pepper mild mottle virus as viral water quality 720
monitoring tools—potential, research gaps, and way forward. Current Opinion in Environmental 721
Science & Health 16, 54-61, doi:https://doi.org/10.1016/j.coesh.2020.02.001 (2020). 722
42 Rosario, K., Symonds, E. M., Sinigalliano, C., Stewart, J. & Breitbart, M. Pepper Mild 723
Mottle Virus as an Indicator of Fecal Pollution. 75, 7261-7267, doi:10.1128/AEM.00410-724
09 %J Applied and Environmental Microbiology (2009). 725
43 Schrader, C., Schielke, A., Ellerbroek, L. & Johne, R. PCR inhibitors – occurrence, properties 726
and removal. 113, 1014-1026, doi:https://doi.org/10.1111/j.1365-2672.2012.05384.x (2012). 727
44 Bivins, A. et al. Persistence of SARS-CoV-2 in Water and Wastewater. Environmental Science & 728
Technology Letters 7, 937-942, doi:10.1021/acs.estlett.0c00730 (2020). 729
45 Dada, A. C. & Gyawali, P. Quantitative microbial risk assessment (QMRA) of occupational 730
exposure to SARS-CoV-2 in wastewater treatment plants. Science of The Total Environment, 731
142989, doi:https://doi.org/10.1016/j.scitotenv.2020.142989 (2020). 732
46 Fuqua, J. L. et al. A rapid assessment of wastewater for genomic surveillance of SARS-CoV-2 733
variants at sewershed scale in Louisville, KY. 2021.2003.2018.21253604, 734
doi:10.1101/2021.03.18.21253604 %J medRxiv (2021). 735
47 Fontenele, R. S. et al. High-throughput sequencing of SARS-CoV-2 in wastewater provides 736
insights into circulating variants. 2021.2001.2022.21250320, 737
doi:10.1101/2021.01.22.21250320 %J medRxiv (2021). 738
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
34
48 Whitney, O. N. et al. Sewage, Salt, Silica, and SARS-CoV-2 (4S): An Economical Kit-Free 739
Method
for Direct Capture of SARS-CoV-2 RNA from Wastewater. Environ Sci Technol 55, 740
4880-4888, doi:10.1021/acs.est.0c08129 (2021). 741
49 Pecson, B. M. et al. Reproducibility and sensitivity of 36 methods to quantify the SARS-CoV-2 742
genetic signal in raw wastewater: findings from an interlaboratory methods evaluation in the U.S. 743
Environmental Science: Water Research & Technology 7, 504-520, doi:10.1039/D0EW00946F 744
(2021). 745
50 Mascola, J. R., Graham, B. S. & Fauci, A. S. SARS-CoV-2 Viral Variants—Tackling a Moving 746
Target. JAMA 325, 1261-1262, doi:10.1001/jama.2021.2088 %J JAMA (2021). 747
51 Crits-Christoph, A. et al. Genome Sequencing of Sewage Detects Regionally Prevalent SARS-748
CoV-2 Variants. 12, e02703-02720, doi:10.1128/mBio.02703-20 %J mBio (2021). 749
52 Izquierdo-Lara, R. et al. Monitoring SARS-CoV-2 Circulation and Diversity through Community 750
Wastewater Sequencing, the Netherlands and Belgium. Emerging Infectious Disease journal 27, 751
1405, doi:10.3201/eid2705.204410 (2021). 752
53 La Rosa, G. et al. Rapid screening for SARS-CoV-2 variants of concern in clinical and 753
environmental samples using nested RT-PCR assays targeting key mutations of the spike protein. 754
Water Research 197, 117104, doi:https://doi.org/10.1016/j.watres.2021.117104 (2021). 755
756
757
758
. CC-BY-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted May 10, 2021. ; https://doi.org/10.1101/2021.05.06.21256753doi: medRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.